The blood–brain barrier (BBB) exists between plasma and brain tissue. It comprises a
capillary wall and glial cells and prevents external substances, including therapeutic agents …

The blood–brain barrier (BBB) is a specialized semipermeable structure that highly
regulates exchanges between the central nervous system parenchyma and blood vessels …

Lung cancer (LC) has high morbidity and fatality rate that can be attributed to its poor
diagnostic and monitoring facilities. Hence, there is a need to design advanced detection …

The most prevalent and aggressive type of brain cancer, namely, glioblastoma (GBM), is
characterized by intra-and inter-tumor heterogeneity and strong spreading capacity, which …

Magnetic driven targeted drug delivery (TDD) involves the manipulation of magnetic drug
carriers, such as nano/micro particles or bubbles, within the body using external magnetic …

Biogenic and biomimetic nanosystems (BBS) are the advanced hybrid nanomaterial used
for treatment and diagnosis. These nanosystems' true bench-to-bedside potential makes …

Over the past several decades, nanocarriers have demonstrated diagnostic and therapeutic
(ie, theranostic) potencies in translational oncology, and some agents have been further …

Alzheimer's disease (AD), the most common type of dementia, is characterized by senile
plaques composed of amyloid β protein (Aβ) and neurofilament tangles derived from the …

Modern medicine has allowed for many advances in neurological and neurodegenerative
disease (ND). However, the number of patients suffering from brain diseases is ever …

Introduction Central nervous system (CNS)-related disorders are increasingly being
recognized as a global health challenge worldwide. There are significant challenges for …